- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04333030
Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology
August 4, 2021 updated by: Dr Nadia YOUNES, Versailles Hospital
INFO-AIDE-TABAC Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology
this is an observational study that involves providing a questionnaire to patients consulting in psychiatry, addictology (other than tobacco) and endocrinology to assess their knowledge of tobacco risks and access to smoking cessation aids
Study Overview
Study Type
Observational
Enrollment (Actual)
310
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Le Chesnay, France, 78150
- Centre Hospitalier de Versailles
-
Paris, France
- Hôpital Ferdinand Widal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients who come at :
- Department of Psychiatry for Adults of the Hospital of Versailles of Dr N Bazin (André Mignot in Chesnay): CMP (Centre Médico-psychologique), HDJ (Day Hospital).
- Endocrinology service of Dr JP Beressi of the Hospital of Versailles (André Mignot in Chesnay): consultation, HDJ
- Addictology service CSAPA (Espace Murger) by Dr F Vorspan of the Fernand-Widal Hospital in Paris
Description
Inclusion Criteria:
- Patients > 18 years
- Men and women
- who comes for consultation during the study
- Psychiatry on CMP or HDJ, regardless of diagnosis or smoking status
- Endocrinology in consultation or HDJ
- In addictology at CSAPA
Exclusion Criteria:
- Patient unable to complete questionnaire (not speaking French, confused, alcoholics, etc.)
- Refusal to complete questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Psychiatry
patients who come for psychiatric consultation
|
Tobacco Use and Risk Questionnaire
|
addictology (other than tabacco)
patients who come for addictology consultation
|
Tobacco Use and Risk Questionnaire
|
endocrinology
patients who come for endocrinology consultation
|
Tobacco Use and Risk Questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
to Assess the level of information on tobacco-related risks of patients with questionnaire
Time Frame: at the end of study, average 2 month
|
to Assess the level of information on tobacco-related risks of patients monitored for psychiatric disorders by comparing them to patients monitored for an addiction other than tobacco or to patients monitored for a chronic disease
|
at the end of study, average 2 month
|
to Assess access to smoking cessation aids for smokers and ex-smokers with questionnaire
Time Frame: at the end of study, average 2 month
|
to Assess access to smoking cessation aids for smokers and ex-smokers among psychiatric patients compared to smokers and ex-smokers among patients who have been monitored for an addiction other than tobacco or among patients who have been monitored for a chronic disease (endocrine).
|
at the end of study, average 2 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 12, 2019
Primary Completion (Actual)
June 30, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
February 28, 2020
First Submitted That Met QC Criteria
April 2, 2020
First Posted (Actual)
April 3, 2020
Study Record Updates
Last Update Posted (Actual)
August 5, 2021
Last Update Submitted That Met QC Criteria
August 4, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- P19/12_info_aide_tabac
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Consumption, Tobacco
-
Institut national de prevention et d'education...CompletedTobacco ConsumptionFrance
-
Yale UniversityVA Connecticut Healthcare SystemCompletedTobacco Use | Alcohol ConsumptionUnited States
-
Cairo UniversityNot yet recruiting
-
RTI InternationalKula Vyema Centre of Food Economics; Jomo Kenyatta University of Agriculture...Not yet recruiting
-
NYU Langone HealthRecruitingCalorie ConsumptionUnited States
-
The University of Hong KongCompleted
-
University of South CarolinaGlobal Alliance for Improved NutritionCompleted
-
RTI InternationalUniversity of Abuja; Datametrics Associates Ltd; University of Nigeria NsukkaRecruiting
-
Cairo UniversityNot yet recruiting
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)CompletedAlcohol Consumption | Hazardous Alcohol ConsumptionCanada
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
Rabin Medical CenterCompleted
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
National Taiwan University HospitalNational Taiwan UniversityUnknownComputerized Physician Order EntryTaiwan
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed